Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Balt USA, LLC

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Balt USA, LLC

Regulatory records
6
Linked recall entries
3
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 6 FDA records to the applicant name Balt USA, LLC. The collection includes 3 510(k) clearances. It includes 1 original PMA approval. 2 entries are PMA supplements. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Jan 27, 2026 to Oct 16, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code SGU appears in 3 of the 6 linked filings. The collection spans 3 FDA product codes and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P250009, with 3 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 3 linked filings have a current plain-language explanation checked against the recorded FDA decision.

Applicant mailing address recorded by FDA: 29 Parker, Irvine, CA, 92618. Recorded on P250009/S001, decision dated Oct 16, 2026.

Changes described in PMA records

P250009/S001: SQUID Liquid Embolic Agent (LEA)

The FDA record for P250009/S001, dated 2026-10-16, shows approval of the protocol for the COSMIC post-approval study, submitted under the normal 180-day track with no user fee. The supplement reason is listed as Postapproval Study Protocol, tied to the SQUID Liquid Embolic Agent (LEA), product code SGU, in neurology, submitted by Balt USA, LLC. The record does not describe the protocol's design, endpoints, sample size, or the conditions it addresses.

The source statement indicates the protocol was submitted to comply with conditions of approval in the original P250009 order. That wording is the agency's reported purpose, not independent evidence of safety or clinical effectiveness. The record does not show a change to the device's indications or labeling, and the six-character identifier alone does not confirm the original approval date or the full scope of the parent PMA. The decision applies to the PAS protocol, not a new approval of the whole system.

FDA approval-order wording

Approval of the protocol for the COSMIC post-approval study (PAS). The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P250009.

Oct 16, 2026 · Normal 180 Day Track No User Fee

P250009/S002: SQUID Liquid Embolic Agent (LEA)

The FDA record for P250009/S002, dated 2026-09-09, shows an approval for changes to the mixing time for the SQUID Liquid Embolic Agent (LEA). It is classified as a real-time process supplement under the labeling-change reason covering indications, instructions, shelf life, or tradename. The record lists the device category as a neurovascular liquid embolic agent and the specialty as neurology, with Balt USA, LLC as applicant. The specific before-and-after mixing times are not given in the supplied fields.

The S002 identifier links the action to the preceding PMA P250009 as a supplement, not a new approval of the whole system. The record's reported purpose describes a process change to mixing time; it does not establish safety or clinical effectiveness independently. The supplied fields also omit whether the change is accompanied by revised labeling text, what prompted the change, and which shelf-life or instruction sections were affected.

The supplement type is listed as "Real-Time Process," and the stated purpose is confined to the mixing time, so no broader technical detail, trial result, or new indication should be inferred from this entry.

FDA approval-order wording

Approval for changes to the mixing time for the SQUID Liquid Embolic Agent (LEA).

Sep 9, 2026 · Real-Time Process

P250009: SQUID Liquid Embolic Agent (LEA)

FDA approved the SQUID Liquid Embolic Agent from Balt USA, LLC on January 30, 2026. The approval covers embolization of the middle meningeal artery as an adjunct to usual care in patients with symptomatic chronic subdural hematoma measuring 10 mm or greater in thickness, when a neurosurgeon determines an intervention is necessary.

The database record lists the device category as neurovascular liquid embolic agent, the specialty as neurology, and the product code as SGU. The record does not include a supplement type or supplement reason, so no additional change to a prior approval is described. The statement reports an intended use; it does not independently establish safety or clinical effectiveness.

FDA approval-order wording

The SQUID Liquid Embolic Agent is indicated for the embolization of the middle meningeal artery (MMA) as an adjunct to usual care treatment in patients with symptomatic chronic subdural hematoma(s) (SDH) measuring 10 mm or greater in thickness in whom an intervention is deemed necessary as determined by a neurosurgeon.

Jan 30, 2026

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

RECALL COVERAGE

Recalls linked to this firm

MedtechLedger links 3 FDA enforcement entries through the recorded recalling firm or an exact submission number published in FDA’s recall data. 1 Class I, 2 Class II records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.

Recall / productCompanyClassificationReport dateSource
Balt USA, LLCClass INov 5, 2025FDA
Optima Coil System REFs/UDI-DI codes: OPTI0156BLK 00810068568875 OPTI0158BLK 00810068568882 OPTI0103BLK 00810068568851 OPTI0258BLK 00810068568929 OPTI0212BLK 00810068568912 OPTI0206BLK 00810068568905 OPTI0310BLK 00810068568943 OPTI0320BLK 00810068568950 OPTI0151HSS10 00818053026614 OPTI0152HSS10 00840303701002 OPTI0153HSS10 00840303701019 OPTI0154CSS10 00818053025761 OPTI0154HSS10 00840303701026 OPTI1027CST10 00840303700142 OPTI1030HST10 00818053027086 OPTI1034COM18 00818053026461 OPTI1137COM18 00818053026478 OPTI1550COM18 00818053026515 OPTI0101CSS10 00818053025709 OPTI0101HSS10 00840303700951 OPTI0102CSS10 00818053025716 OPTI0102HSS10 00840303700968 OPTI0103HSS10 00818053026591 OPTI0103CSS10 00818053025723 OPTI0104HSS10 00818053026607 OPTI0254CSS10 00840303700548 OPTI0255CSF10 00840303700203 OPTI0256CSS10 00818053025853 OPTI0256HSS10 00818053026737 OPTI0202HSS10 00840303701040 OPTI0203HSS10 00840303701057 OPTI0203CSS10 00818053025785 OPTI0204CSS10 00840303700494 OPTI0204HSS10 00840303701064 OPTI0206CSF10 00818053026027 OPTI0206CSS10 00818053025808 OPTI0208CSF10 00818053026034 OPTI0208HSS10 00840303701088 OPTI0208CSS10 00840303700517 OPTI0358CSS10 00818053025921 OPTI0310HSS10 00840303701156 OPTI0310CSS10 00818053025907 OPTI0310HSF10 00840303700814 OPTI0310CSF10 00840303700234 OPTI0304HSS10 00840303701125 OPTI0304HSF10 00840303700784 OPTI0304CSS10 00818053025877 OPTI0306HSS10 00840303701132 OPTI0308HSS10 00840303701149 OPTI0308CSF10 00818053026065 OPTI0308CSS10 00840303700593 OPTI0410CSS10 00840303700654 OPTI0410HSF10 00840303700852 OPTI0413CSF10 00818053026119 OPTI0406HSS10 00840303701163 OPTI0408HSS10 00818053026799 OPTI0413CST10 00840303700036 OPTI0510HSS10 00840303701217 OPTI0510CSS10 00840303700685 OPTI0510HSF10 00840303700890 OPTI0513CSS10 00840303700692 OPTI0517CSF10 00818053026157 OPTI0517CST10 00840303700050 OPTI0508CSS10 00840303700678 OPTI0509CSF10 00818053026140 OPTI0610HSF10 00840303700937 OPTI0611CSF10 00818053026171 OPTI0620CSF10 00840303700357 OPTI0620HST10 00840303700715 OPTI0713CST10 00840303700081 OPTI0713CSF10 00840303700364 OPTI0724CSF10 00818053026218 OPTI0724CST10 00840303700098 OPTI0724COM18 00818053026430 OPTI0827CSF10 00818053026232 OPTI0827CST10 00840303700111 OPTI0923CST10 00818053026379 OPTI0930COM18 00818053026454 OPTI0153HSSMX 00818053025419 OPTI1040CSFMX 00818053025280 OPTI1245CSFMX 00818053025303 OPTI1445CSFMX 00818053025327 OPTI1650CSFMX 00818053025341 OPTI0103CSSMX 00840303701408 OPTI2525CSSMX 00840303701477 OPTI0255CSSMX 00818053025020 OPTI0202CSSMX 00818053024979 OPTI3535CSSMX 00818053025068 OPTI0310CSSMX 00818053025051 OPTI0307CSSMX 00818053025044 OPTI4510CSFMX 00818053025143 OPTI4545CSFMX 00818053025136 OPTI0413CSFMX 00818053025129 OPTI0404CSFMX 00818053025099 OPTI0407CSFMX 00818053025105 OPTI0510CSFMX 00818053025167 OPTI0507CSFMX 00818053025150 OPTI0715CSFMX 00818053025228 OPTI0720CSFMX 00818053025235 OPTI0930CSFMX 00818053025266 The Optima Coil System consists of an implantable embolization coil comprised of a platinum-tungsten alloy attached to a proximal stainless steel hypotube and distal body coil delivery pusher with a radiopaque distal positioning marker and a proximal fluorosafe marker. The Optima Coil delivery pusher is 185cm in length. It is designed for use with the XCEL Detachment Controller. The XCEL Detachment Controller comes pre-loaded with batteries and is a sterile, handheld, single patient-use device which should not be reused, re-sterilized, opened or tampered with. The Optima Coil achieves detachment by an internal heater element, which is powered by the XCEL Detachment Controller. The Optima Coil System and XCEL Detachment Controller(s) are sold separately.Z-1988-2025
Balt USA, LLCClass IIJun 25, 2025FDA
Prestige Coil System REFs/UDI-DI codes: PRES0153CXPPLT 00810068567311 PRES1045CPKPLT 00810068567663 PRES1245CPKPLT 00810068567694 PRES1445CPKPLT 00810068567724 PRES0103CXPPLT 00810068567304 PRES2512CXPPLT 00810068567397 PRES0258CXPPLT 00810068567380 PRES0212CXPPLT 00810068567373 PRES0204CXPPLT 00810068567342 PRES0206CXPPLT 00810068567359 PRES0208CXPPLT 00810068567366 PRES3520CXPPLT 00810068567441 PRES3530CXPPLT 00810068567458 PRES0310CXPPLT 00810068567403 PRES0320CXPPLT 00810068567410 PRES0420CPKPLT 00810068567489 PRES0517CPKPLT 00810068567519 PRES0540CPKPLT 00810068568028 PRES0620CPKPLT 00810068567557 PRES0635CPKPLT 00810068567564 PRES0650CPKPLT 00810068567571 PRES0720CPKPLT 00810068567588 PRES0735CPKPLT 00810068567595 PRES0750CPKPLT 00810068567601 PRES0830CPKPLT 00810068567618 PRES0845CPKPLT 00810068567625 PRES0153HXPPL 00818053027147 PRES0204HXPPL 00818053029943 PRES0204CXPPL 00818053027321 PRES0208HXPPL 00818053029981 PRES0315HXPPL 00818053027178 PRES0307CXPPL 00818053027376 PRES0420HPKPL 00818053027185 PRES0440HPKPL 00810068567830 PRES0520HPKPL 00818053027192 PRES0540HPKPL 00810068567847 PRES0650HPKPL 00810068567854 PRES0720HPKPL 00818053027215 PRES0750HPKPL 00810068567861 PRES0830HPKPL 00818053027222 The Prestige Coil System consists of an implantable embolization coil comprised of a platinum-tungsten alloy attached to a proximal stainless steel hypotube and distal body coil delivery pusher with a radiopaque distal positioning marker and a proximal fluorosafe marker. The Optima Coil delivery pusher is 185cm in length. It is designed for use with the XCEL Detachment Controller. The XCEL Detachment Controller comes pre-loaded with batteries and is a sterile, handheld, single patient-use device which should not be reused, re-sterilized, opened or tampered with. The Optima Coil achieves detachment by an internal heater element, which is powered by the XCEL Detachment Controller. The Optima Coil System and XCEL Detachment Controller(s) are sold separately.Z-1989-2025
Balt USA, LLCClass IIJun 25, 2025FDA

Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.

Source information

Source updated Nov 11, 2026. Retrieved Nov 21, 2026.

Devices & associated records

Product / regulatory recordCompanyPathwayDecision dateSource
Balt USA, LLCPMA supplementOct 16, 2026FDA
Balt USA, LLCPMA supplementSep 9, 2026FDA
Balt USA, LLC510(k) clearanceJul 13, 2026FDA
Balt USA, LLC510(k) clearanceApr 16, 2026FDA
Balt USA, LLCPMA approvalJan 30, 2026FDA
Balt USA, LLC510(k) clearanceJan 27, 2026FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.